European shares slip in cyclical-defensive tug of war
Reuters
Published Dec 05, 2017 05:30AM ET
Updated Dec 05, 2017 05:40AM ET
European shares slip in cyclical-defensive tug of war
By Helen Reid
LONDON (Reuters) - European shares surrendered on Tuesday to sliding cyclicals, as a rotation out of tech stocks gathered pace and dwindling enthusiasm over a U.S. tax bill weighed on financial services.
Eurozone blue chips (STOXX50E), fresh from their best day in five months, fell 0.2 percent, as weak tech, financials and healthcare shares outweighed a rally in consumer staples and utilities.
After rallies in the United States and Asia fizzled out overnight, European benchmarks fell as investors took profit in tech and reached for safer, high-dividend-paying stocks.
Unilever (L:ULVR) and Danone (PA:DANO) gained the most. Utilities Enel (MI:ENEI) and E.ON (DE:EONGn) also advanced.
"It's been noticeable there has been a distinct sector rotation over the last week which is impacting the momentum of the market," wrote Deutsche Bank strategist Jim Reid in a note.
Euro zone banks (SX7P) slipped after their best gains in two months, falling 0.3 percent. Santander (MC:SAN), BNP Paribas (PA:BNPP) and Deutsche Bank (DE:DBKGn) were among those losing ground after gaining in the previous session.
UBS analysts noted that although lower taxes on future U.S. earnings would help European banks, U.S. banks would benefit more, giving them a competitive advantage.
British sub-prime lender Provident Financial (L:PFG) fell 13 percent after UK regulator FCA opened an investigation into its Moneybarn unit.
Chipmakers led the tech sector (SX8P) down. Ams (S:AMS) fell 2.4 percent after rising 213 percent this year, making it by far the best-performing European stock of 2017.
The iPhone supplier Dialog Semiconductor (DE:DLGS) bucked the trend. After sinking 24 percent on fears Apple (O:AAPL) would in-source its chip production, it recovered to trade up 4.2 percent, even though RBC analysts cut their rating.
Mining companies were the worst-performing as metals prices slipped.
Healthcare stocks were also bruised, led down by Sanofi (PA:SASY). The Philippines stopped sales of its dengue vaccine after the company warned it could worsen the disease in some cases.
The healthcare sector has underperformed the market this year, and Goldman Sachs (NYSE:GS) strategists wrote investors are "still struggling to come to terms with a punishing Q3 reporting season... and broad sentiment remaining depressed."
Get The News You Want
Luxury brand Moncler (MI:MONC) was top of Italian stocks, up 2.2 percent after Deutsche Bank upgraded it to "buy" in a note forecasting healthy growth for the luxury sector in 2018.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.